NeuroOne receives Notice of Allowance for drug-delivery neural probe patent

NEUROONE MEDICAL TECHNOLOGIES Corp

USPTO issued Notice of Allowance for Patent App. 16/812,702 covering electrodes that deliver treatment agent to brain target.
This is the third Notice of Allowance received by NeuroOne in recent months.
Company expects patent issuance in the coming months.
CEO says allowance strengthens IP portfolio and supports partnering for combination drug-delivery and sEEG recording.
NeuroOne's portfolio now includes 3 allowed apps, 1 issued patent, 8 pending U.S. apps, and several foreign apps.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.